Get the Stockscreener App
14.78
0.13%
-0.02
89 Bio Inc stock is traded at $14.78, with a volume of 831.22K.
It is down -0.13% in the last 24 hours and up +83.15% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$14.80
Open:
$14.81
24h Volume:
831.22K
Relative Volume:
0.21
Market Cap:
$2.19B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-7.5025
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
-0.60%
1M Performance:
+83.15%
6M Performance:
+167.28%
1Y Performance:
+89.74%
1-Day Range:
$14.78
$14.83
1-Week Range:
$14.75
$14.89
52-Week Range:
$4.16
$15.06
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
14.78 | 2.20B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.81 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.25 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.14 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Buy |
| Mar-14-25 | Initiated | Goldman | Neutral |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
Investors Purchase High Volume of Put Options on 89BIO (NASDAQ:ETNB) - Defense World
Roche commences tender offer for all shares of 89bio, Inc. - GlobeNewswire
$20.50 Per Share Deal: Roche Makes Move to Acquire 89bio in Major Biotech Tender Offer - Stock Titan
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash - Yahoo Finance
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal - MSN
Kala Bio Stock Just Plunged 89% Today – Here’s What Happened - Stocktwits
Why 89bio Inc. stock is rated strong buy2025 Biggest Moves & Verified Entry Point Detection - newser.com
Technical analysis overview for 89bio Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Will 89bio Inc. stock split attract more investorsWeekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
Is 89bio Inc. stock attractive for retirement portfoliosWeekly Stock Report & Momentum Based Trading Ideas - newser.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders - GlobeNewswire Inc.
Backtesting results for 89bio Inc. trading strategiesQuarterly Trade Review & Short-Term High Return Strategies - newser.com
How 89bio Inc. stock reacts to global recession fearsBear Alert & Community Consensus Picks - newser.com
Measuring 89bio Inc.’s beta against major indicesEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
89bio, Inc. Hits New 52-Week High of $15.06, Up 76.62% - Markets Mojo
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB) - PR Newswire
How to integrate 89bio Inc. into portfolio analysis toolsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Applying chart zones and confluence areas to 89bio Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Real time breakdown of 89bio Inc. stock performance2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Roche To Buy 89bio For Up To $3.5 Billion - Pulse 2.0
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger - MSN
Will 89bio Inc. continue its uptrendPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Published on: 2025-09-19 14:02:20 - newser.com
Has 89bio Inc. found a price floor2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
89bio Stock Price, Quotes and Forecasts | NASDAQ:ETNB - Benzinga
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc.ETNB - Business Wire
Dow Update: Is 89bio Inc trading at a discountWeekly Trade Analysis & Reliable Price Breakout Alerts - خودرو بانک
Roche to Buy 89bio for Up to $3.5 Billion in Obesity Push - MSN
89bio Inc. stock chart pattern explainedMarket Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Roche Makes Major MASH Bid, Offering $2.4bn For 89bio - insights.citeline.com
Roche’s 89bio Buyout: Building A Combo-Ready Metabolic Franchise Beyond GLP-1 Wars (RHHBY) - Seeking Alpha
Roche Scoops Up 89bio In A $2.4 Billion Deal - Finimize
89bio: Pegozafermin MASH Drug Advancement Nets Roche Acquisition (NASDAQ:ETNB) - Seeking Alpha
Roche To Buy 89bio in $3.5 Billion Deal - USA Herald
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push - Benzinga
Roche Expands Cardiometabolic Pipeline With 89bio Acquisition (OTCMKTS:RHHBY) - Seeking Alpha
RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline - Yahoo Finance
MASH dash speeds up as Roche acquires 89bio for up to $3.5B - BioWorld MedTech
Roche deal to buy 89bio boosts MASH space (ETNB:NASDAQ) - Seeking Alpha
Is ETNB Stock a Bargain or a Risk? - StocksToTrade
Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion - The Wall Street Journal
89bio Stock Surge: Time to Invest? - timothysykes.com
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Why Did 89bio Stock Nearly Double In Value Today? - Stocktwits
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders - Business Wire
Roche to Buy Biopharmceutical Firm 89bio in $3.5 Billion Deal - Bloomberg.com
Roche enters into a definitive merger agreement to acquire - GlobeNewswire
Roche Holding AG agreed to acquire 89bio, Inc. for $2.2 billion in a tender offer transaction. - MarketScreener
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):